European Archives - Page 66 of 1095 - European Medical Journal

Ozanimod▼ in Ulcerative Colitis: Key New Data

A summary of the latest ozanimod data presented at UEGW and ACG 2024, confirming the continuing long-term efficacy and safety profile of…

Coagulase-Negative Staphylococcal Endocarditis: A Nationwide Study Reveals Key Trends

A large Spanish cohort study highlights the distinct clinical features, management, and outcomes of coagulase-negative staphylococcal endocarditis.

Personalising Overactive Bladder Treatment: Why BMI Matters in Choosing the Right Therapy

Women who are overweight with refractory overactive bladder respond better to botulinum toxin injections than pharmaceutical therapy, new research finds.

Genetic Analysis of 527 Cases of Rare Bleeding Disorders: EAHAD 2025

Genetic analysis of 527 rare bleeding disorder cases reveals novel variants, according to research presented at the EAHAD 2024 Annual Congress.

Reclassification of Haemophilia Carriers Improves Diagnosis and Care: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, a new system improves diagnosis and care for hemophilia carriers.

miRNA Signatures as Biomarkers for Haemophilic Arthropathy: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, miRNA signatures could serve as biomarkers for hemophilic arthropathy.

Emerging Risks of Spinal Stenosis in Older People with Haemophilia: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, spinal stenosis is increasingly common in aging hemophilia patients.

Nurse-Led Education for Female Haemophilia Carriers: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, nurse-led education empowers female hemophilia carriers across life stages.

The Hidden Burden of RSV in Primary Care

A new study across five European countries highlights the impact of RSV on clinical outcomes, healthcare utilisation, and family life.

Pseudomonas Infection Triggers Lung Transplant Rejection Through Immune Disruption

Pseudomonas aeruginosa infection drives lung transplant rejection by inducing regulatory T cell death and promoting B cell responses.